Which blood biomarkers actually matter for longevity?

Short answer: many blood markers predict long-term health and mortality, but the most actionable ones reflect cardiovascular risk, metabolic (glucose/insulin) control, systemic inflammation, kidney/liver function, and basic nutrition/hematologic status. Below are the high-value biomarkers, why they matter, what direction is desirable, and practical testing options.

High-value biomarkers (what they measure and why they matter)

• ApoB / non‑HDL cholesterol (and LDL-C)

  • Why: ApoB (or non‑HDL) better captures atherosclerotic particle burden than HDL alone; strongly linked to cardiovascular events and longevity.
  • Direction: lower is better; targets depend on risk (discuss with clinician).

• Lp(a) (lipoprotein(a))

  • Why: genetically determined CVD risk factor not changed by lifestyle; high levels increase early CVD risk.
  • Direction: identify high levels to guide more aggressive risk reduction.

• HbA1c and fasting glucose (plus fasting insulin or HOMA-IR)

  • Why: glycemic control predicts diabetes and vascular complications; insulin resistance predicts metabolic aging.
  • Direction: aim for normal glycemia; even high‑normal values predict higher long‑term risk.

• High-sensitivity CRP (hs‑CRP) and other inflammatory markers (IL‑6, GlycA)

  • Why: chronic low-grade inflammation strongly predicts cardiovascular disease, frailty, and mortality.
  • Direction: lower is better. IL‑6 and GlycA are more specialized but informative.

• High-sensitivity cardiac troponin and NT‑proBNP

  • Why: sensitive markers of subclinical cardiac injury and cardiac strain; predict heart failure and mortality even in asymptomatic people.
  • Direction: lower is better.

• eGFR (creatinine) and cystatin C

  • Why: kidney function predicts all‑cause mortality; cystatin C can detect earlier decline.
  • Direction: higher eGFR / lower cystatin C within normal ranges is better.

• Albumin (serum albumin)

  • Why: low albumin signals malnutrition, inflammation, frailty; predicts mortality, especially in older adults.
  • Direction: higher (within normal) is better.

• Complete blood count parameters: hemoglobin, RDW, white blood cell count

  • Why: anemia, high RDW, and elevated WBC associate with poorer outcomes and mortality.
  • Direction: within normal, avoid anemia/elevated RDW/WBC.

• Liver enzymes (GGT, ALT, AST)

  • Why: GGT and other enzymes correlate with metabolic health, alcohol use, fatty liver — all linked to long‑term risk.
  • Direction: lower/normal.

• Vitamin D (25‑OH D), B12, ferritin

  • Why: deficiencies relate to frailty, falls, cognitive decline, and worse outcomes.
  • Direction: replete to optimal ranges recommended by clinicians.

• Thyroid function (TSH ± free T4)

  • Why: thyroid disorders affect metabolism, cardiovascular risk, cognition, and longevity.
  • Direction: euthyroid state is best.

• IGF‑1 (and growth factor signaling)

  • Why: IGF‑1 is implicated in aging biology; relationships are complex (both low and high levels have risks). Useful in research/clinical contexts but interpret cautiously.
  • Direction: mid‑range may be preferable; discuss with a specialist.

• ApoA1, omega‑3 index

  • Why: ApoA1/HDL functionality and omega‑3 status associate with cardiovascular mortality risk.
  • Direction: higher omega‑3 index associated with lower risk.

• Homocysteine

  • Why: elevated homocysteine links to vascular and cognitive risk; often modifiable with B vitamins if elevated.

Advanced/optional tests (use if higher risk, family history, or for research/optimization)

• NMR lipoprofile (LDL particle number — LDL‑P)
• GlycA (NMR inflammation marker)
• Specialized cytokines (IL‑6, TNF‑α)
• Genetic tests (APOE genotype relevant to Alzheimer risk; LPA gene for Lp(a) insights)
• Telomere length and epigenetic clocks — interesting for research but not yet routine clinical guidance

Practical testing — where to get them (brands/services)

• Clinical labs (for physician-ordered tests): Quest Diagnostics, LabCorp, Mayo Clinic Laboratories — comprehensive, reliable, widely used by doctors.
• Direct-to-consumer / consumer-friendly platforms (some tests available without a clinician visit; discuss abnormal results with your provider):
  • InsideTracker — broad, action-oriented panels plus lifestyle recommendations.
  • Everlywell and LetsGetChecked — home collection kits for common labs (lipids, HbA1c, thyroid, vitamin D).
  • OmegaQuant — specialized omega‑3 index testing.
  • Cleveland HeartLab — specialized cardiovascular inflammation and advanced lipid testing.
  • SpectraCell — micronutrient testing (if you suspect nutrient deficiencies). Note: ApoB, Lp(a), NMR lipoprofile and high-sensitivity cardiac markers are available through major clinical labs (Quest/LabCorp) and some specialty services.

How to use this information

• Prioritize based on age and risk:
  • Under ~40 and low risk: basic lipid panel, fasting glucose or HbA1c, CBC, CMP, vitamin D as needed.
  • Over ~40 or with family history: add ApoB (or non‑HDL), Lp(a) once, hs‑CRP, eGFR/cystatin C, hs‑troponin/NT‑proBNP if cardiac risk.
  • Known metabolic/CVD disease: more frequent, include advanced lipid testing and inflammatory markers.
• Frequency: annually for stable adults; every 3–6 months if changing therapy, abnormal results, or higher risk.
• Actionability matters: use labs that will change management (lifestyle or meds). For example, high ApoB or LDL → statin discussion; high HbA1c → lifestyle + medical therapy; elevated hs‑CRP/IL‑6 → focus on anti‑inflammatory lifestyle changes and treat risk factors.

Bottom line Focus first on cardiovascular risk (ApoB/non‑HDL, LDL, Lp(a)), glycemic control (HbA1c/glucose/insulin resistance), and chronic inflammation (hs‑CRP, IL‑6). Complement that with kidney/liver function, basic nutrition/hematologic labs, vitamin D/B12, and targeted cardiac markers (NT‑proBNP, hs‑troponin) when indicated. Use trusted clinical labs (Quest, LabCorp, Mayo) for diagnostic accuracy and consider consumer services (InsideTracker, OmegaQuant, Cleveland HeartLab) for additional or convenience testing. Always review abnormal results with your clinician to plan interventions tailored to your overall risk.

If you want, tell me your age, sex, family history and any known conditions and I’ll suggest a prioritized list of tests and how often to check them.